tradingkey.logo

Mangoceuticals Inc

MGRX
0.713USD
-0.597-45.57%
收盤 12/19, 16:00美東報價延遲15分鐘
9.90M總市值
0.01本益比TTM

Mangoceuticals Inc

0.713
-0.597-45.57%

關於 Mangoceuticals Inc 公司

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc簡介

公司代碼MGRX
公司名稱Mangoceuticals Inc
上市日期Mar 21, 2023
CEOCohen (Jacob D)
員工數量- -
證券類型Ordinary Share
年結日Mar 21
公司地址15110 Dallas Pkwy, Suite 600
城市DALLAS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75248
電話18336264679
網址https://www.mangorx.com/
公司代碼MGRX
上市日期Mar 21, 2023
CEOCohen (Jacob D)

Mangoceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
128.33K
-7.23%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
1.67K
-98.68%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
128.33K
-7.23%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
1.67K
-98.68%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月21日 週五
更新時間: 11月21日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Cohen (Jacob D.)
8.48%
Navy Wharf, Ltd.
6.50%
Propre Energie Inc
4.22%
Greenfield Investments Ltd
3.35%
The Vanguard Group, Inc.
1.25%
其他
76.20%
持股股東
持股股東
佔比
Cohen (Jacob D.)
8.48%
Navy Wharf, Ltd.
6.50%
Propre Energie Inc
4.22%
Greenfield Investments Ltd
3.35%
The Vanguard Group, Inc.
1.25%
其他
76.20%
股東類型
持股股東
佔比
Corporation
15.57%
Individual Investor
12.74%
Investment Advisor
1.71%
Investment Advisor/Hedge Fund
0.77%
Venture Capital
0.20%
其他
69.00%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
27
301.64K
2.21%
-28.95K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
2023Q3
19
652.27K
63.81%
+112.43K
2023Q2
12
649.40K
63.58%
+115.75K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Cohen (Jacob D.)
1.30M
12.39%
+500.00K
+62.11%
Jul 21, 2025
Navy Wharf, Ltd.
1.00M
9.49%
+1.00M
--
May 27, 2025
Propre Energie Inc
650.00K
6.17%
--
--
May 27, 2025
Greenfield Investments Ltd
515.00K
4.89%
--
--
May 27, 2025
The Vanguard Group, Inc.
182.61K
1.73%
+182.61K
--
Jun 30, 2025
Myers (Kenny)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
D'Alessio (Lorraine Pamela)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
Johnston (Eugene M)
138.33K
1.31%
+100.00K
+260.87%
Sep 09, 2025
Geode Capital Management, L.L.C.
26.50K
0.25%
+6.93K
+35.40%
Jun 30, 2025
Isaac (Antonios)
60.00K
0.57%
--
--
May 27, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
公告日期
類型
比率
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1

常見問題

Mangoceuticals Inc的前五大股東是誰?

Mangoceuticals Inc的前五大股東如下:
Cohen (Jacob D.)
持有股份:1.30M
佔總股份比例:12.39%。
Navy Wharf, Ltd.
持有股份:1.00M
佔總股份比例:9.49%。
Propre Energie Inc
持有股份:650.00K
佔總股份比例:6.17%。
Greenfield Investments Ltd
持有股份:515.00K
佔總股份比例:4.89%。
The Vanguard Group, Inc.
持有股份:182.61K
佔總股份比例:1.73%。

Mangoceuticals Inc的前三大股東類型是什麼?

Mangoceuticals Inc 的前三大股東類型分別是:
Cohen (Jacob D.)
Navy Wharf, Ltd.
Propre Energie Inc

有多少機構持有Mangoceuticals Inc(MGRX)的股份?

截至2025Q3,共有27家機構持有Mangoceuticals Inc的股份,合計持有的股份價值約為301.64K,占公司總股份的2.21% 。與2025Q2相比,機構持股有所增加,增幅為-27.42%。

哪個業務部門對Mangoceuticals Inc的收入貢獻最大?

在--,--業務部門對Mangoceuticals Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI